[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100651723":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":24,"centralContacts":27,"locations":24,"responsibleParty":33,"collaborators":35,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":43,"acronym":24,"eligibilityCriteria":44,"healthyVolunteers":41,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":24,"studyType":51,"phases":52,"briefSummary":54,"conditions":55,"keywords":24,"overallStatus":57,"whyStopped":24,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":24},{"fullName":5,"class":6},"China National Center for Cardiovascular Diseases","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Percutaneous pulsed field ablation performed under ultrasound-only guidance.","EXPERIMENTAL","Percutaneous pulsed field ablation is performed under ultrasound-only guidance in patients with paroxysmal atrial fibrillation.",[13],"Procedure: Percutaneous pulsed field ablation is performed under ultrasound-only guidance in patients with paroxysmal atrial fibrillation.",{"label":15,"type":16,"description":17,"interventionNames":18},"Pulsed field ablation performed under fluoroscopic guidance","ACTIVE_COMPARATOR","Patients with paroxysmal atrial fibrillation underwent percutaneous pulsed field ablation under fluoroscopic guidance.",[19],"Procedure: Patients with paroxysmal atrial fibrillation underwent percutaneous pulsed field ablation under fluoroscopic guidance.",[21,25],{"type":22,"name":11,"description":11,"armGroupLabels":23,"otherNames":24},"PROCEDURE",[9],null,{"type":22,"name":17,"description":17,"armGroupLabels":26,"otherNames":24},[15],[28],{"name":29,"role":30,"phone":31,"phoneExt":24,"email":32},"MIN TANG, Doctor","CONTACT","86+ 13810665178","doctordangmin@sina.com",{"type":34,"investigatorFullName":24,"investigatorTitle":24,"investigatorAffiliation":24,"oldNameTitle":24,"oldOrganization":24},"SPONSOR",[36],{"name":37,"class":38},"Hangzhou Dinova EP Technology Co., Ltd","INDUSTRY","100651723","a-comparative-study-of-percutaneous-pulsed-field-ablation-guided-by-ultrasound-alone-versus-fluoroscopy-in-patients-with-atrial-fibrillation-100651723",false,"NCT07762742","A Comparative Study of Percutaneous Pulsed Field Ablation Guided by Ultrasound Alone Versus Fluoroscopy in Patients With Atrial Fibrillation","Inclusion Criteria:\n\n* Adult patients aged 18 to 75 years (including 18 years and 75 years of age).\n* Patients diagnosed with paroxysmal atrial fibrillation via 12-lead electrocardiography or ambulatory electrocardiography and scheduled to undergo pulsed field ablation.\n* Subjects are able to understand the purpose of the study, voluntarily participate in the study and sign the informed consent, and are willing to complete the follow-up according to the requirements of the program.\n\nExclusion Criteria:\n\n* Atrial fibrillation secondary to electrolyte imbalance, thyroid disorders, or reversible non-cardiac causes;\n* Previous history of catheter ablation or cardiac surgery for atrial fibrillation;\n* Prior surgical history including patent foramen ovale closure, atrial septal defect closure or repair;\n* Implantation of left atrial appendage occluder, mechanical mitral valve prosthesis, or valvuloplasty ring containing metallic materials;\n* Concomitant other tachyarrhythmias requiring catheter ablation (e.g., atrioventricular reentrant tachycardia, atrioventricular nodal reentrant tachycardia, atrial tachycardia, atrial flutter, Wolff-Parkinson-White syndrome, etc.);\n* Persistent atrial fibrillation;\n* Left atrial anteroposterior diameter (LAD) \\> 55 mm on transthoracic echocardiography;\n* Women who are pregnant, breastfeeding, or of childbearing age with plans to become pregnant during the clinical trial;\n* Current participation in another pharmaceutical or medical device clinical study.","ALL","18 Years","75 Years",{"count":49,"type":50},276,"ESTIMATED","INTERVENTIONAL",[53],"NA","This prospective, randomized, multicenter, open-label, non-inferiority interventional study aims to compare the therapeutic efficacy of percutaneous pulsed field ablation (PFA) guided by ultrasound alone versus fluoroscopy in patients with paroxysmal atrial fibrillation (AF). The success rate of complete electrical isolation of pulmonary veins during the procedure was compared to verify that ultrasound-only guidance is non-inferior to fluoroscopic guidance.",[56],"Paroxysmal Atrial Fibrillation (PAF)","NOT_YET_RECRUITING","2026-08-11",{"date":60,"type":61},"2026-08-13","ACTUAL",{"date":63,"type":50},"2026-08-15",{"date":65,"type":50},"2029-02-28",{"name":5,"class":6}]